Jing Rong
Directeur/Membre du Conseil chez Cmbi Capital Management Shenzhen Co. Ltd.
Profil
Jing Rong is currently an Executive Director at Cmbi Capital Management Shenzhen Co. Ltd.
Prior to this, he worked as a Director at EpimAb Biotherapeutics, Inc. and as a Director at Burning Rock Biotech Ltd.
from 2017 to 2022.
He also served as Vice President-Investment Funds at China Merchants Capital Management Co., Ltd.
from 2012 to 2015.
Mr. Rong holds an MBA from The Chinese University of Hong Kong, which he earned in 2012, and an undergraduate degree from Xiamen University, which he earned in 2003.
Postes actifs de Jing Rong
| Sociétés | Poste | Début |
|---|---|---|
| Cmbi Capital Management Shenzhen Co. Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jing Rong
| Sociétés | Poste | Fin |
|---|---|---|
| BURNING ROCK BIOTECH LIMITED | Directeur/Membre du Conseil | 24/06/2022 |
China Merchants Capital Management Co., Ltd.
 China Merchants Capital Management Co., Ltd. Investment ManagersFinance China Merchants Capital Management Co., Ltd. engages in the management of equity investment. It also involves in investment consulting activities. The company was founded on June 20, 2012 and is headquartered in Shenzhen, China. | Corporate Officer/Principal | 01/01/2015 |
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Directeur/Membre du Conseil | - |
Formation de Jing Rong
| Xiamen University | Undergraduate Degree |
| The Chinese University of Hong Kong | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BURNING ROCK BIOTECH LIMITED | Health Services |
| Entreprise privées | 3 |
|---|---|
| Cmbi Capital Management Shenzhen Co. Ltd. | |
China Merchants Capital Management Co., Ltd.
China Merchants Capital Management Co., Ltd. Investment ManagersFinance China Merchants Capital Management Co., Ltd. engages in the management of equity investment. It also involves in investment consulting activities. The company was founded on June 20, 2012 and is headquartered in Shenzhen, China. | Finance |
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Health Technology |
